DYN

Dyne Therapeutics is a biotechnology company developing treatments for rare muscle diseases. The company uses a technology platform called FORCE to create medicines for conditions like muscular dystrophy and Pompe disease, which cause muscles to weaken or stop working properly. The company was founded in 2017 and is based in Massachusetts. Their medicines are still in clinical testing stages, meaning they have not yet been approved by regulators for patients to use.